Product
Supplier
Encyclopedia
Inquiry
Trizepatide 20mg buy - large image1
Trizepatide 20mg buy - image1
Trizepatide 20mg buy - image2
Trizepatide 20mg buy - image3
Trizepatide 20mg buy - image4
Trizepatide 20mg buy - image5
Trizepatide 20mg buy - image6

Trizepatide 20mg

2081 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

qingdao

Brand:

tengchu

Packaging:

5mg/box,10mg/box

Price valid (until):

2024-10-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

ghk-cu,Semaglutide,tirzepatide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Contact me 

    Email: tengchu03@zhuanjinbio.com

    whatsapp:+852 94445081


    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 1 Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 2 Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 3


     

      Specification  

     
    Items Specifications
    Product name Tirzepatide
    Delivery 5 working days
    Specification 5mg*10vials
    10mg*10vials
    15mg*10vials
    Whatsapp +852-9444-5081
    Package 10 vials/box





     

      Company profile

     


    Qingdao Xinli Technology Development Co., Ltd.address is in Qingdao, and the service is good.      Our customers come from different countries, such as the United States, Europe, Japan, Korea, India and so on.       The company is committed to the separation, purification and chiral separation of high purity natural products, as well as the development, production and marketing of API intermediates.    The company mainly engaged in high-end monomer products of natural medicinal plants, semi-synthetic derivatives of medicinal plant ingredients, chemical synthetic products, high-end natural food and cosmetic additives.    The company is a research and development and innovation as one of the high-tech Co., LTD.      Years of technology research and development, with excellent design concept to meet customer needs, to provide customers with differentiated products.


    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 5
    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 6



     

      FAQ


    Q:Can we print our logo on the product?

    A:Of course, we can do it. Just send us your logo design.


    Q:How about the price? Can you make it cheaper?

    A:We always take the customer's benefit as the top priority. Price is negotiable under different conditions, we are assuring you to get the most competitive price.


    Q:Do you offer free samples?

    A:A 5Stars Review=A Free Sample It's appreciated that you could write us positive reviews if you like our products and service, we will offer you some free samples on your next order.


    Q:How Can I place an order?

    A:You could directly place an order via Alibaba, and sure you could just send us inquiry to any of our sales representatives to get detailed order information, and we will explain' the detail process.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    ghk-cu,Semaglutide,tirzepatide,Retatrutide

    Location:

    Room 68-5-501, Lianqiang Residential Area, No. 371 Union Road, Union Street, Xinhua District, Shijiazhuang City, Hebei Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    5

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2022

  • Inquiry History
    2081 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    Poland

    TIRZEPATIDE

    10 MG Feb 18, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.